Keros Therapeutics Inc (KROS) Price Prediction & ForecastKROSKeros Therapeutics Inc

Alphio's KROS stock price prediction model matches the current Keros Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.01 (-0.21%). The 1-week path is $11.12 (+0.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Keros Therapeutics Inc is not a strong buy at the moment, with a current price of $11.03 and a forward P/E ratio of 48.78 indicating high valuation expectations. The stock has seen a significant year-to-date decline of 40.51%, which raises concerns about its recovery potential. Additionally, the recent disappointing earnings report showed an EPS of -1.45, missing estimates by 16%, which may further undermine investor confidence. The main risk is the lack of near-term clinical catalysts, as noted by analysts, which could lead to continued bearish sentiment.

Keros Therapeutics Inc (KROS) last closed at $11.03, losing -1.78%. These facts feed the 1-day and 1-week KROS price prediction above.